[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100545256":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":18,"responsibleParty":35,"collaborators":37,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":18,"eligibilityCriteria":45,"healthyVolunteers":42,"sex":46,"minAge":47,"maxAge":48,"enrollmentInfo":49,"targetDuration":18,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":60,"overallStatus":66,"whyStopped":18,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":18},{"fullName":5,"class":6},"NuvoAir Medical PC","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"NuvoAir clinical service","EXPERIMENTAL","Patients with COPD receiving usual care plus the NuvoAir clinical service.The NuvoAir clinical service offers comprehensive remote monitoring of health parameters and patient-reported outcomes as well as personalized clinical and behavioral interventions tailored to the patients' unique needs and clinical risk. The service involves virtual interaction with NuvoAir coaches who provide guidance and assistance in navigating and utilizing the service; dedicated NuvoAir care coordinators for self-management support and educational resources, aiming to enhance the management of COPD and other comorbidities including cardiovascular conditions. In situations where patients encounter new or worsening symptoms, the NuvoAir clinical team is accessible to advise and triage as required.",[13],"Other: NuvoAir clinical service",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard Care","NO_INTERVENTION","Propensity matched controls with COPD who receive usual care.",null,[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":18},"OTHER","Patients with COPD receiving usual care plus NuvoAir clinical services.",[9],[25],{"name":26,"affiliation":27,"role":28},"Ken Cohen, MD","Executive Director of Translational Research, OptumCare","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"Eric Harker, MD","CONTACT","(303)748-5781","eric.harker@nuvoair.com",{"type":36,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[38],{"name":39,"class":6},"Optum, Inc.","100545256","the-copd-care-study-evaluating-the-impact-of-a-virtual-first-copd-service-on-major-cardiac-and-respiratory-events-100545256",false,"NCT06379529","The COPD CARE Study: Evaluating the Impact of a Virtual-First COPD Service on Major Cardiac and Respiratory Events","Inclusion Criteria:\n\n* Twelve months of claims data in the health insurer or provider's database for baseline\n* ICD10 code for COPD (including emphysema and chronic bronchitis) with a severe exacerbation of COPD in the previous 12 months (defined as ER visit or hospitalization related to COPD or severity score of 2 or 3)\n* Cooperative, i.e., subject should be able to follow and understand instructions\n* Access to a phone (smartphone, cell phone, or landline)\n* Willingness to sign a medical release form for treating healthcare facilities\n\nExclusion Criteria:\n\n* Does not have access to a a phone (smartphone, cell phone, or landline)\n* Lack of cooperation, subject cannot follow and understand instructions\n* Other serious medical illness that, in the opinion of the PI, would interfere with the patient's participation in the study or interpretation of their data (i.e., terminal illness, unstable psychiatric condition, etc.)\n* Does not understand English","ALL","30 Years","100 Years",{"count":50,"type":51},1050,"ESTIMATED","INTERVENTIONAL",[54],"NA","A 12 month interventional study of up to 1,050 people with COPD to determine if the NuvoAir virtual-first clinical service leads to fewer moderate and severe COPD exacerbations and cardiac events, reduces healthcare utilization, and lowers the total cost of care compared to a control cohort that receives standard care only.",[57,58,59],"COPD Exacerbation","COPD","Cardio\u002FPulm: Heart Failure",[58,57,61,62,63,64,65],"COPD Hospitalization","COPD Readmission","COPD Costs","Medicare","Medicare Advantage","NOT_YET_RECRUITING","2025-05-23",{"date":69,"type":70},"2025-05-28","ACTUAL",{"date":72,"type":51},"2026-01-01",{"date":74,"type":51},"2027-12-01",{"name":5,"class":6}]